Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
The company has raised US$4.5 million in funding for its AI operating system
Q2FY24 EBITDA up by 105% y-o-y at Rs. 28 crore
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Total transaction value of the divestment is Rs. 3,660 million
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
Subscribe To Our Newsletter & Stay Updated
